Used and new tyre.
Transformers, lighting, rf, inductors.
Steel Products , Aluminum Products And Seamless Steel Pipes.
Oil and gas.
Crude oil, liquified gas, aviation kerosene, light cycle oil, naphta, gasoline, diesel, mazut, copper concentrate, iron ore, copper cathode.Import, supply and buying center
Optimal air filtration For homes and businesses: The 5000 series is our most popular line of air purifiers, with the most available options and the best value for maximum air cleaning. Choose from this series for the ideal indoor air Quality solution for most homes and businesses. Featuring up to 27 pounds of activated carbon for effective chemical, gas and odor adsorption, plus a hepa filtration system to remove particles that trigger allergies and asthma. These air cleaners provide the perfect protection for average-size rooms (max 1, 500 square feet), and come in a wide array of colors to match any décor. 50 lbs.
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
Jp54, Jeta1, D2, D6, En590, Mazut, Urea, Etc.
Jet fuel (jp 54 and jet A-1), crude oil, D2 diesel oil, mazut M100 (origin: russia, cameroon), unleaded premium, kerosene gasoline, natural gas (LPG, LNG).Clearing agent and trading
